02.093,(Z)-Non-6-en-1-ol,35854-86-5,324,10294,,,,JECFA,
02.110,2,6-Dimethylhept-6-en-1-ol,36806-46-9,348,,At least 90 %; secondary component 5-10 % 2,6-dimethyl-5-hepten-1-ol,,,JECFA,
02.145,2,6-Dimethylocta-1,5,7-trien-3-ol,29414-56-0,,,,,,EFSA,
02.194,Octa-1,5-dien-3-ol,83861-74-9,,,,,,EFSA,
02.211,Undeca-1,5-dien-3-ol,56722-23-7,,,,,,EFSA,
02.229,(-)-3,7-Dimethyl-6-octen-1-ol,7540-51-4,,,At least 90 % cis-isomer; secondary components 2-6 % di-unsaturated and saturated C10 alcohols, 2-4 % citronellyl acetate and 2-3 % citronellal,,,EFSA,
02.252,4,8-Dimethyl-3,7-nonadien-2-ol,67845-50-5,1841,,,,,EFSA,
05.026,o-Tolualdehyde,529-20-4,,,,,,EFSA,
05.028,m-Tolualdehyde,620-23-5,,,,,,EFSA,
05.029,p-Tolualdehyde,104-87-0,,,,,,EFSA,
05.085,(Z)-Hept-4-enal,6728-31-0,320,2124,At least 93 % of Z-form of hept-4-enal; secondary component 2-5 % of E-form of hept-4-enal.,,,JECFA,
05.137,Dec-4(cis)-enal,21662-09-9,,,At least 90 %; secondary component at least 5 % trans-isomer,,,EFSA,
05.182,2,6,6-Trimethylcyclohex-2-ene-1-carboxaldehyde,432-24-6,,,,,,EFSA,
07.190,Octa-1,5-dien-3-one,65213-86-7,1848,,Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form,,,EFSA,
07.198,Pseudo-ionone,141-10-6,,11191,,,,EFSA,
07.202,2,6,6-Trimethylcyclohex-2-en-1-one,20013-73-4,,,,,,EFSA,
07.204,3,3,6-Trimethylhepta-1,5-dien-4-one,546-49-6,,,,,,EFSA,
07.255,l-Piperitone,4573-50-6,1856,,,,,EFSA,
08.004,Lactic acid,50-21-5,930,4,,,,EFSA,
09.016,Menthyl acetate,16409-45-3,431,206,,,,JECFA,
09.131,DL-Isobornyl propionate,2756-56-1,1391,412,,,,EFSA,
09.132,Benzyl propionate,122-63-4,842,413,,,,EFSA,
09.266,Hexyl 2-butenoate,19089-92-0,1807,10688,,,,EFSA,
09.562,trans-3-Hexenyl formate,56922-80-6,,,,,,EFSA,
09.578,Hexyl (E)-but-2-enoate,1617-25-0,,10688,,,,EFSA,
09.596,Isopentyl-(Z)-but-2-enoate,10482-55-0,,,,,,EFSA,
09.854,cis-3-Hexenyl 2-methylbutanoate,53398-85-9,,,,,,EFSA,
09.858,Phenylmethyl 2-methyl-2-butenoate,67674-41-3,,,Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form,,,EFSA,
09.880,(Z)-Hept-4-en-2-yl butanoate,94088-12-7,,,,,,EFSA,
09.936,4,8-Dimethyl-3,7-nonadien-2-yl acetate,91418-25-6,1847,,,,,EFSA,
12.075,Methyl prop-1-enyl disulfide,5905-47-5,569,11712,At least 90 %; secondary components 3-4 % dimethyl disulfide and 3-4 % di-1-propenyl disulfide,,,JECFA,
12.086,S-Methyl 2-methylbutanethioate,42075-45-6,486,,,,,JECFA,
12.273,3-(Methylthio)heptanal,51755-70-5,1692,,At least 92 %; secondary component 5-7 % (E)-hept-2-enal,,,EFSA,
13.028,2-Butyl-5 or 6-keto-1,4-dioxane,65504-95-2,1484,2206,,,,EFSA,
13.170,2S-cis-Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran,3033-23-6,,,,,,EFSA,
13.190,3-((2-methyl-3-furyl)thio)-2-butanone,61295-44-1,1525,,,,,EFSA,
14.067,2-Ethoxy-3-methylpyrazine,32737-14-7,793,11921,At least 82 % 2-ethoxy-3-methylpyrazine. Secondary components 15 % 2–ethoxy-5-methylpyrazine (CAS no 67845-34-5) or 2-ethoxy-6-methylpyrazine (CAS no 53163-97-6),,,EFSA,
15.134,2,5-Dihydroxy-1,4-dithiane,40018-26-6,550,,Mixture of diastereoisomers: 25-30 % of (2S,5S and 2R,5R) and 70-75 % (2S,5R and 2R,5S),,,EFSA,
16.095,Cyclopropanecarboxamide, N-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-,744251-93-2,1779,,,,,EFSA,
16.123,(1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide,68489-09-8,,,,,,EFSA,
17.015,DL-Methylmethioninesulphonium chloride,3493-12-7,1427,761,,,,EFSA,